Biotech · Private company

Almac

Track this companyFree. Adds Almac to your Dealase workspace and tells you when its record changes.

Clinical trials41 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable TumorsPHASE2 · RECRUITING · started Dec 21, 2023ClinicalTrials.gov NCT05280314 · fetched Nov 12, 2026
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHDPHASE4 · COMPLETED · started Jun 2, 2023ClinicalTrials.gov NCT05721235 · fetched Nov 12, 2026
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHDPHASE4 · COMPLETED · started Mar 22, 2023ClinicalTrials.gov NCT05685732 · fetched Nov 12, 2026
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBCPHASE2 · COMPLETED · started Apr 11, 2022ClinicalTrials.gov NCT05077709 · fetched Nov 12, 2026